BALDWIN WEALTH PARTNERS LLC/MA

Position in NVCT — Nuvectis Pharma, Inc.

CIK 1021258 Marion, MA

Position in NVCT

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$7,025,255

+$4,098,484 QoQ

Shares Held

382,015

+0.9% QoQ

Ownership

1.44%

of shares outstanding

% of Portfolio

0.56%

of 13F equity value

Holder Rank

of 6 holders

Holding Since

Jun 2022

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BALDWIN WEALTH PARTNERS LLC/MA holds $21,986,639 across 4 Biotechnology names. NVCT ranks #2 (32.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	44,070	$10,787,013
2	NVCT	Nuvectis Pharma, Inc. This page	382,015	$7,025,255
3	VRTX	Vertex Pharmaceuticals Inc / Ma	7,824	$3,886,414
4	LGND	Ligand Pharmaceuticals Inc	911	$287,957

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,025,255	382,015	+0.9%	Shares	Sole	2026-07-14
2026-03-31	$2,926,771	378,625	-2.8%	Shares	Sole	2026-04-14
2025-12-31	$2,941,668	389,625	+11.2%	Shares	Sole	2026-01-07
2025-09-30	$2,109,775	350,461	0.0%	Shares	Sole	2025-10-14
2025-06-30	$2,617,943	350,461	-2.2%	Shares	Sole	2025-07-24
2025-03-31	$3,502,163	358,461	+0.7%	Shares	Sole	2025-04-14
2024-12-31	$1,925,749	355,961	+104.4%	Shares	Sole	2025-01-22
2024-09-30	$1,095,277	174,130	+3.3%	Shares	Other	2024-10-16
2024-06-30	$1,067,427	168,630	+9.4%	Shares	Other	2024-07-12
2024-03-31	$1,263,866	154,130	+8.5%	Shares	Sole	2024-04-12
2023-12-31	$1,184,613	142,040	+22.0%	Shares	Other	2024-01-08
2023-09-30	$1,500,138	116,380	+29.2%	Shares	Other	2023-10-10
2023-06-30	$1,438,274	90,061	-37.4%	Shares	Other	2023-07-14
2023-03-31	$1,885,218	143,800	+7.9%	Shares	Sole	2023-04-21
2022-12-31	$999,750	133,300	+0.2%	Shares	Sole	2023-01-27
2022-09-30	$942,970	133,000	+9.9%	Shares	Sole	2022-10-14
2022-06-30	$1,355,200	121,000	—	Shares	Sole	2022-07-18
No filing history on record for this holder in this stock.